Abstract:Background The head-twitch response (HTR) in mice is considered a behavioral model for hallucinogens and serotonin 5-HT 2A receptor function, as well as Tourette syndrome in humans. It is mediated by 5-HT 2A receptor agonists such as ( ±)− 2,5-dimethoxy-4-iodoamphetamine (DOI) in the prefrontal cortex (PFC). The 5-HT 2A antagonist EMD 281014, can prevent both DOI-induced HTR during ageing and c-fos expression in different regions of PFC. Moreover, the nonselective monoamine releaser methamphetamine (MA) suppressed DOI-induced HTR through ageing via concomitant activation of inhibitory 5-HT 1A receptors, but enhanced DOI-evoked c-fos expression. d -Fenfluramine is a selective 5-HT releaser and induces HTR in mice, whereas MA does not. Currently, we investigated whether EMD 281014 or MA would alter: (1) d -fenfluramine-induced HTR frequency in 20-, 30- and 60-day old mice, (2) d -fenfluramine-evoked c- fos expression in PFC, and (3) whether blockade of inhibitory serotonergic 5-HT 1A - or adrenergic ɑ 2 -receptors would prevent suppressive effect of MA on d -fenfluramine-induced HTR. Results EMD 281014 (0.001–0.05 mg/kg) or MA (0.1–5 mg/kg) blocked d -fenfluramine-induced HTR dose-dependently during ageing. The 5-HT 1A antagonist WAY 100635 countered the inhibitory effect of MA on d -fenfluramine-induced HTR in 30-day old mice, whereas the adrenergic ɑ 2 antagonist RS 79948 reversed MA’s inhibitory effect in both 20- and 30- day old mice. d -Fenfluramine significantly increased c- fos expressions in PFC regions. MA (1 mg/kg) pretreatment significantly increased d -fenfluramine-evoked c- fos expression in different regions of PFC. EMD 281014 (0.05 mg/kg) failed to prevent d -fenfluramine-induced c- fos expression, but significantly increased it in one PFC region (PrL at − 2.68 mm). Conclusion EMD 281014 suppressed d -fenfluramine-induced HTR but failed to prevent d -fenfluramine-evoked c- fos expression which suggest involvement of additional serotonergic receptors in the mediation of evoked c- fos . The suppressive effect of MA on d -fenfluramine-evoked HTR is due to well-recognized functional interactions between stimulatory 5-HT 2A - and the inhibitory 5-HT 1A - and ɑ 2 -receptors. MA-evoked increases in c- fos expression in PFC regions are due to the activation of diverse monoaminergic receptors through increased synaptic concentrations of 5-HT, NE and/or DA, which may also account for the additive effect of MA on d -fenfluramine-evoked changes in c- fos expression. Our findings suggest potential drug receptor functional interaction during development when used in combination.

Effects of Low-Doses of Methamphetamine on D-Fenfluramine-induced Head-Twitch Response (HTR) in Mice During Ageing and C-Fos Expression in the Prefrontal Cortex

An Ontogenic Study of Receptor Mechanisms by Which Acute Administration of Low-Doses of Methamphetamine Suppresses DOI-induced 5-Ht2a-receptor Mediated Head-Twitch Response in Mice

Ultra-low doses of methamphetamine suppress 5-hydroxytryptophan-induced head-twitch response in mice during aging

Metabolites Alterations in the Medial Prefrontal Cortex of Methamphetamine Users in Abstinence: A 1H MRS Study

Constrasting Effects of Dopaminergic Blockade on MDMA and D-Amphetamine Conditioned Taste Aversions

Fenfluramine evokes 5-HT2A receptor-mediated responses but does not displace [11C]MDL 100907: small animal PET and gene expression studies

Psilocin Suppresses Methamphetamine‐induced Hyperlocomotion and Acquisition of Conditioned Place Preference Via D2R‐mediated ERK Signaling

Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice

Exposure to Far Infrared Ray Protects Methamphetamine-Induced Behavioral Sensitization in Glutathione Peroxidase-1 Knockout Mice via Attenuating Mitochondrial Burdens and Dopamine D1 Receptor Activation

Comparison of some behavioral effects of d- and l-methamphetamine in adult male rats

Effects of Multiple High-Dose Methamphetamine Administration on Enteric Dopaminergic Neurons and Intestinal Motility in the Rat Model

Two Inbred Strains of Rats, Fischer 344 and Lewis, Showed Differential Behavior and Brain Expression of Corticosterone Receptor mRNA Induced by Methamphetamine

Exposure to far-infrared ray attenuates methamphetamine-induced impairment in recognition memory through inhibition of protein kinase C δ in male mice: Comparison with the antipsychotic clozapine

In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat

Tetrahydropalmatine Protects Against Methamphetamine-Induced Spatial Learning and Memory Impairment in Mice

Effects of fentanyl and the adulterant levamisole on the rewarding and locomotor effects of methamphetamine in rats

Single-dose methamphetamine administration impairs ORM retrieval in mice via excessive DA-mediated inhibition of PrL Glu activity

The role of heterodimers formed by histamine H3 receptors and dopamine D1 receptors on the methamphetamine-induced conditioned place preference

Dextromethorphan moderates reward deficiency associated with central serotonin transporter availability in 3,4-methylenedioxy-methamphetamine-treated animals

Effects of the designer drug 4-methylamphetamine on core temperature and serotonin levels in the striatum and hippocampus of rats

Basolateral Amygdala Serotonin 2C Receptor Regulates Emotional Disorder-Related Symptoms Induced by Chronic Methamphetamine Administration